Non-communicable neurological disorders: Analysis of the distribution and temporal trend of Alzheimer's disease in various countries of America
DOI:
https://doi.org/10.70577/asce.v5i1.592Keywords:
Americas, Comparative analysis, Nervous system disease, Mental illness, MortalityAbstract
The rising incidence rates of Alzheimer's disease and other types of dementia have led to an increase in public health problems. The objective of this research is to analyze the distribution and temporal trends of Alzheimer's disease in various countries of the Americas between 2010 and 2021. A quantitative, qualitative, descriptive, and critical approach was used; data from the Pan American Health Organization (PAHO) were employed; the mortality rate calculated per 100,000 inhabitants was analyzed; and the countries evaluated were the United States, Mexico, Bolivia, Colombia, Ecuador, and Peru. Alzheimer's disease and other related dementias in the Americas had a population average of 7.67 per 100,000 inhabitants in 2010, with the United States having the highest rate in both years evaluated (2010 = 65.8 and 2021 = 82.01). Conversely, in 2010 and 2021, the Peruvian and Mexican populations, respectively, had the lowest rates identified in the evaluation. A high proportion of people over 75 years of age died while suffering from Alzheimer's disease in the United States (2010 = 1042.79 and 2021 = 1111.4), compared to other countries. Finally, in all evaluations, the United States, when compared to developing countries, had a high mortality rate among patients diagnosed with Alzheimer's; furthermore, higher mortality was observed specifically among women. Finally, it is recommended that the information presented be considered when planning current and future social and health services, in order to establish a strategy aimed at mitigating the spread of Alzheimer's.
Downloads
References
Bazargan-Hejazi, S., Dehghan, K., Edwards, C., Mohammadi, N., Attar, S., Sahraian, M. A., & Eskandarieh, S. (2020). The health burden of non-communicable neurological disorders in the USA between 1990 and 2017. Brain Communications, 2(2), fcaa097. https://doi.org/10.1093/braincomms/fcaa097 DOI: https://doi.org/10.1093/braincomms/fcaa097
Feng, J., Wu, Q., Liang, Y., Liang, Y., & Bin, Q. (2025). Epidemiological characteristics of infertility, 1990–2021, and 15-year forecasts: An analysis based on the global burden of disease study 2021. Reproductive Health, 22(1), 26. https://doi.org/10.1186/s12978-025-01966-7 DOI: https://doi.org/10.1186/s12978-025-01966-7
Ho, J. Y. (2022). Causes of America’s Lagging Life Expectancy: An International Comparative Perspective. The Journals of Gerontology: Series B, 77(Supplement_2), S117-S126. https://doi.org/10.1093/geronb/gbab129 DOI: https://doi.org/10.1093/geronb/gbab129
Ho, J. Y., & Franco, Y. (2022). The rising burden of Alzheimer’s disease mortality in rural America. SSM - Population Health, 17, 101052. https://doi.org/10.1016/j.ssmph.2022.101052 DOI: https://doi.org/10.1016/j.ssmph.2022.101052
Kumar, S., Rao, P., Singhania, S., Verma, S., & Kheterpal, M. (2024). Will artificial intelligence drive the advancements in higher education? A tri-phased exploration. Technological Forecasting and Social Change, 201, 123258. https://doi.org/10.1016/j.techfore.2024.123258 DOI: https://doi.org/10.1016/j.techfore.2024.123258
Liang, C.-S., Li, D.-J., Yang, F.-C., Tseng, P.-T., Carvalho, A. F., Stubbs, B., Thompson, T., Mueller, C., Shin, J. I., Radua, J., Stewart, R., Rajji, T. K., Tu, Y.-K., Chen, T.-Y., Yeh, T.-C., Tsai, C.-K., Yu, C.-L., Pan, C.-C., & Chu, C.-S. (2021). Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias: A systematic review and meta-analysis. The Lancet Healthy Longevity, 2(8), e479-e488. https://doi.org/10.1016/S2666-7568(21)00140-9 DOI: https://doi.org/10.1016/S2666-7568(21)00140-9
Mobaderi, T., Kazemnejad, A., & Salehi, M. (2024). Exploring the impacts of risk factors on mortality patterns of global Alzheimer’s disease and related dementias from 1990 to 2021. Scientific Reports, 14(1), 15583. https://doi.org/10.1038/s41598-024-65887-4 DOI: https://doi.org/10.1038/s41598-024-65887-4
Mok, V. C. T., Pendlebury, S., Wong, A., Alladi, S., Au, L., Bath, P. M., Biessels, G. J., Chen, C., Cordonnier, C., Dichgans, M., Dominguez, J., Gorelick, P. B., Kim, S., Kwok, T., Greenberg, S. M., Jia, J., Kalaria, R., Kivipelto, M., Naegandran, K., … Scheltens, P. (2020). Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID‐19 pandemic, now and in the future. Alzheimer’s & Dementia, 16(11), 1571-1581. https://doi.org/10.1002/alz.12143 DOI: https://doi.org/10.1002/alz.12143
Nandi, A., Counts, N., Chen, S., Seligman, B., Tortorice, D., Vigo, D., & Bloom, D. E. (2022). Global and regional projections of the economic burden of Alzheimer’s disease and related dementias from 2019 to 2050: A value of statistical life approach. eClinicalMedicine, 51, 101580. https://doi.org/10.1016/j.eclinm.2022.101580 DOI: https://doi.org/10.1016/j.eclinm.2022.101580
Piovezan, R. D., Oliveira, D., Arias, N., Acosta, D., Prince, M. J., & Ferri, C. P. (2020). Mortality Rates and Mortality Risk Factors in Older Adults with Dementia from Low- and Middle-Income Countries: The 10/66 Dementia Research Group Population-Based Cohort Study. Journal of Alzheimer’s Disease, 75(2), 581-593. https://doi.org/10.3233/JAD-200078 DOI: https://doi.org/10.3233/JAD-200078
Russo, M., De Rosa, M. A., Calisi, D., Consoli, S., Evangelista, G., Dono, F., Santilli, M., Granzotto, A., Onofrj, M., & Sensi, S. L. (2022). Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits. International Journal of Molecular Sciences, 23(19), 11418. https://doi.org/10.3390/ijms231911418 DOI: https://doi.org/10.3390/ijms231911418
Sundström, A., Adolfsson, A. N., Nordin, M., & Adolfsson, R. (2020). Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease. The Journals of Gerontology: Series B, 75(5), 919-926. https://doi.org/10.1093/geronb/gbz139 DOI: https://doi.org/10.1093/geronb/gbz139
Valiukas, Z., Tangalakis, K., Apostolopoulos, V., & Feehan, J. (2025). Microglial activation states and their implications for Alzheimer’s Disease. The Journal of Prevention of Alzheimer’s Disease, 12(1), 100013. https://doi.org/10.1016/j.tjpad.2024.100013 DOI: https://doi.org/10.1016/j.tjpad.2024.100013
Wiese, L. A. K., Gibson, A., Guest, M. A., Nelson, A. R., Weaver, R., Gupta, A., Carmichael, O., Lewis, J. P., Lindauer, A., Loi, S., Peterson, R., Radford, K., Rhodus, E. K., Wong, C. G., Zuelsdorff, M., Saidi, L. G., Valdivieso‐Mora, E., Franzen, S., Pope, C. N., … Babulal, G. M. (2023). Global rural health disparities in Alzheimer’s disease and related dementias: State of the science. Alzheimer’s & Dementia, 19(9), 4204-4225. https://doi.org/10.1002/alz.13104 DOI: https://doi.org/10.1002/alz.13104
Zhao, X., Li, C., Ding, G., Heng, Y., Li, A., Wang, W., Hou, H., Wen, J., & Zhang, Y. (2021). The Burden of Alzheimer’s Disease Mortality in the United States, 1999-2018. Journal of Alzheimer’s Disease, 82(2), 803-813. https://doi.org/10.3233/JAD-210225 DOI: https://doi.org/10.3233/JAD-210225
Zhu, D., Montagne, A., & Zhao, Z. (2021). Alzheimer’s pathogenic mechanisms and underlying sex difference. Cellular and Molecular Life Sciences, 78(11), 4907-4920. https://doi.org/10.1007/s00018-021-03830-w DOI: https://doi.org/10.1007/s00018-021-03830-w
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zaulo Emmanuel Alcaraz Hernández, Elver Kevin Escobedo Alvarez, Vivian Judith Machicado Villarreal, Shirley Elizabeth Sampedro Luna, Guadalupe Isabel Saquipay Duchitanga
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Eres libre de:
- Compartir : copiar y redistribuir el material en cualquier medio o formato
- Adaptar : remezclar, transformar y desarrollar el material
- El licenciante no puede revocar estas libertades siempre y cuando usted cumpla con los términos de la licencia.
En los siguientes términos:
- Atribución : Debe otorgar el crédito correspondiente , proporcionar un enlace a la licencia e indicar si se realizaron cambios . Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o a su uso.
- No comercial : no puede utilizar el material con fines comerciales .
- CompartirIgual — Si remezcla, transforma o construye sobre el material, debe distribuir sus contribuciones bajo la misma licencia que el original.
- Sin restricciones adicionales : no puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otros hacer algo que la licencia permite.
